Back to video list Back to Home How would you choose which CGRP pathway monoclonal antibody medication is for which patient and how do you convince the patient to be on eptinezumab? You may also like Parkinson's Disease Article Early detection and treatment of Parkinson’s disease Migraine Congress highlights Article Restoration of brain function after migraine Schizophrenia Article Glutamate and Oxidative Stress: A novel approach to pathophysiology in schizophrenia Schizophrenia Article Videogames and Psychosis: Concerns versus Opportunities